Clinical Characteristics, Outcomes, and Risk Factors for Patients with Diffuse Large B-Cell Lymphoma and Development of Nomogram to Identify High-Risk Patients

<div>Comparison with current prognostic scoring systems. ROC curves for predicting 5-year OS of our predictive model, IPI, NCCN-IPI, NPI, and Kyoto-index in the training (a) and the validation cohort (b). AUC, area under curve; NPI, the model established by Sun Yat-Sen University Cancer Center (China); Kyoto-index, the model established by Kyoto Prefectural University of Medicine (Japan).</div>

Journal of Oncology

fig4

Figure 4

Figure 4: Clinical Characteristics, Outcomes, and Risk Factors for Patients with Diffuse Large B-Cell Lymphoma and Development of Nomogram to Identify High-Risk Patients 

Figure 4 | Clinical Characteristics, Outcomes, and Risk Factors for Patients with Diffuse Large B-Cell Lymphoma and Development of Nomogram to Identify High-Risk Patients 